ヘルスケア受託研究機関市場：タイプ別、サービス別-2025年～2030年の世界予測

ヘルスケア受託研究機関市場は2023年に568億6,000万米ドルと評価され、2024年には635億2,000万米ドルに達すると予測され、CAGR 11.82%で成長し、2030年には1,243億米ドルに達すると予測されています。

ヘルスケア受託研究機関（CRO）市場には、創薬、臨床試験、データ管理、規制遵守、市販後調査など、製薬、バイオテクノロジー、医療機器部門に提供される幅広いサービスが含まれます。CROは臨床開発の複雑さ、コスト、期間から不可欠な存在であり、企業は市場投入までの時間を短縮し、財務リスクを低減しながらリソースを最適化することができます。用途は前臨床試験から第IV相試験まで、最終用途は製薬、バイオテクノロジー企業、医療機器メーカーに及ぶ。主な成長要因としては、革新的な治療薬に対する需要の高まりによる臨床試験件数の増加、迅速な医薬品承認を求める規制当局の圧力、研究開発費の拡大などが挙げられます。ビッグデータ、人工知能、機械学習の進歩を促進するヘルスケアのデジタル変革は、特に臨床試験の効率化、患者募集、データ分析に新たな機会をもたらしています。アジア太平洋やラテンアメリカなどの新興市場は、臨床研究活動の活発化と良好な規制環境に後押しされ、大きな可能性を示しています。しかし、厳しい規制要件、複雑な契約管理、高い運営コストなどの課題に直面しています。知的財産に関する懸念や熟練した専門家の不足が、市場力学をさらに複雑にしています。成長機会を活かすため、CROは最先端のデジタルソリューションの統合を優先し、戦略的パートナーシップを構築し、希少疾患や個別化医療などのニッチな研究分野に注力すべきです。イノベーションの目標は、自動化によるプロセスの合理化と、患者中心の試験デザインの育成です。市場成長の可能性とは裏腹に、市場競争は依然激しく、戦略的差別化と強固な品質コンプライアンスが必要です。事業の持続的成長には、各国の規制状況を遵守しながら世界展開に投資することが重要です。その結果、CRO市場には課題と機会がダイナミックに混在しており、市場をリードするためには俊敏性と革新性が必要となります。

市場力学：急速に進化するヘルスケア受託研究機関市場の主要市場インサイトを公開

ヘルスケア受託研究機関市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬企業によるエンド・ツー・エンド・サービスのアウトソーシング動向の高まり
  • 再生医療への投資の拡大
  • 専門的な検査サービスへのニーズの高まり
• 市場抑制要因
  • 熟練した専門家の減少
• 市場機会
  • バイオシミラーや生物製剤分野からの需要の高まり
  • ヘルスケア受託研究機関による新技術の導入
• 市場の課題
  • ヘルスケアCROサービスの品質問題

ポーターの5つの力：ヘルスケア受託研究機関市場をナビゲートする戦略ツール

ポーターの5つの力」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘルスケア受託研究機関市場における外部からの影響の把握

外部マクロ環境要因は、ヘルスケア受託研究機関市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘルスケア受託研究機関市場における競合情勢の把握

ヘルスケア受託研究機関市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘルスケア受託研究機関市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘルスケア受託研究機関市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘルスケア受託研究機関市場における成功への道筋を描く

ヘルスケア受託研究機関市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬会社によるエンドツーエンドのアウトソーシングの傾向が増加
    • 再生医療への投資増加
    • 専門検査サービスのニーズ増加
  • 抑制要因
    • 熟練した専門家の減少
  • 機会
    • バイオシミラーおよび生物製剤分野からの新たな需要
    • ヘルスケア契約調査機関による新技術の導入
  • 課題
    • ヘルスケアCROサービスの品質問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘルスケア受託研究機関市場：タイプ別

• 臨床
  • フェーズI試験サービス
  • フェーズ II試験サービス
  • フェーズIII試験サービス
  • フェーズIV試験サービス
• 創薬
  • リードの特定
  • リード最適化
  • ターゲット検証
• 前臨床

第7章 ヘルスケア受託研究機関市場：サービス別

• 生物統計学
• 臨床モニタリング
• データ管理
• 調査員への支払い
• 研究室
• メディカルライティング
• 患者と施設の募集
• プロジェクト管理/臨床供給管理
• 品質管理/保証
• 規制/医療関連
• テクノロジー

第8章 南北アメリカのヘルスケア受託研究機関市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のヘルスケア受託研究機関市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのヘルスケア受託研究機関市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced Clinical
• Charles River Laboratories, Inc.
• Eurofins Scientific SE
• ICON plc
• IQVIA Inc.
• KCR S.A.
• Labcorp Drug Development
• Medpace, Inc.
• Parexel International Corporation
• Pharmaron
• PPD LLC by Thermo Fisher Scientific Inc.
• SGS Societe Generale de Surveillance SA
• Syneos Health
• Syngene International Limited
• WuXi AppTec

LIST OF FIGURES

• FIGURE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET RESEARCH PROCESS
• FIGURE 2. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET DYNAMICS
• TABLE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT & SITE RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 47. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 69. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 70. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 73. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 74. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 85. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 89. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 90. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 93. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 94. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 97. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 98. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 101. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 102. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 105. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 106. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 109. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 110. VIETNAM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 114. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 115. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 118. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 119. DENMARK HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 122. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 123. EGYPT HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 126. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 127. FINLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 130. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 131. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 134. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 135. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 138. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 139. ISRAEL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 142. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 143. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 146. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 147. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 150. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 151. NIGERIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 154. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 155. NORWAY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 158. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 159. POLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 162. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 163. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 166. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 167. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 170. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 171. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 178. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 179. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 182. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 183. SWEDEN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 186. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 187. SWITZERLAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 190. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 191. TURKEY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 194. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 195. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 198. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 199. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
• TABLE 200. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 201. HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023

The Healthcare Contract Research Organization Market was valued at USD 56.86 billion in 2023, expected to reach USD 63.52 billion in 2024, and is projected to grow at a CAGR of 11.82%, to USD 124.30 billion by 2030.

The healthcare contract research organization (CRO) market encompasses a broad range of services provided to pharmaceutical, biotechnology, and medical device sectors, including drug discovery, clinical trials, data management, regulatory compliance, and post-market surveillance. CROs are indispensable due to the complexity, cost, and duration of clinical development, enabling companies to accelerate time-to-market and optimize resources with reduced financial risk. The application scope spans from preclinical studies to Phase IV trials, while end-use extends to pharmaceuticals, biotechnology firms, and medical device manufacturers. Key growth factors include the rising number of clinical trials driven by increasing demand for innovative therapeutics, regulatory pressure demanding faster drug approvals, and expanding R&D expenditure. The digital transformation of healthcare, fostering advancements in big data, artificial intelligence, and machine learning, presents new opportunities, particularly in enhancing trial efficiency, patient recruitment, and data analytics. Emerging markets, like Asia-Pacific and Latin America, exhibit significant potential, driven by increased clinical research activities and favorable regulatory environments. However, the market faces challenges such as stringent regulatory requirements, complex contract management, and high operational costs. Intellectual property concerns and a shortage of skilled professionals further complicate market dynamics. To capitalize on growth opportunities, CROs should prioritize integration of cutting-edge digital solutions, forge strategic partnerships, and focus on niche research areas such as rare diseases and personalized medicine. Innovation should target streamlining processes through automation and fostering patient-centric trial designs. Despite its growth potential, the market's nature remains competitive, necessitating strategic differentiation and robust quality compliance. Investing in global expansion while ensuring adherence to local regulatory landscapes will be crucial for sustained business growth. Consequently, the CRO market presents a dynamic blend of challenges and opportunities, necessitating agility and innovation for market leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Research Organization Market

The Healthcare Contract Research Organization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing trend of outsourcing end-to-end services by pharmaceutical companies
  • Growing investments in regenerative medicine
  • Increasing need among specialized testing services
• Market Restraints
  • Reduced skilled professionals
• Market Opportunities
  • Emerging demand from biosimilars and biologics sector
  • Incorporation of novel technologies by healthcare contract research organizations
• Market Challenges
  • Quality issues of healthcare CRO services

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Research Organization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Research Organization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Research Organization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Research Organization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Research Organization Market

A detailed market share analysis in the Healthcare Contract Research Organization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Research Organization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Research Organization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Research Organization Market

A strategic analysis of the Healthcare Contract Research Organization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Research Organization Market, highlighting leading vendors and their innovative profiles. These include Advanced Clinical, Charles River Laboratories, Inc., Eurofins Scientific SE, ICON plc, IQVIA Inc., KCR S.A., Labcorp Drug Development, Medpace, Inc., Parexel International Corporation, Pharmaron, PPD LLC by Thermo Fisher Scientific Inc., SGS Societe Generale de Surveillance SA, Syneos Health, Syngene International Limited, and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Research Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead Identification, Lead Optimization, and Target Validation.
• Based on Service, market is studied across Bio-Statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient & Site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • 5.1.1.2. Growing investments in regenerative medicine
    • 5.1.1.3. Increasing need among specialized testing services
  • 5.1.2. Restraints
    • 5.1.2.1. Reduced skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging demand from biosimilars and biologics sector
    • 5.1.3.2. Incorporation of novel technologies by healthcare contract research organizations
  • 5.1.4. Challenges
    • 5.1.4.1. Quality issues of healthcare CRO services
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Healthcare Contract Research Organization Market, by Type

• 6.1. Introduction
• 6.2. Clinical
  • 6.2.1. Phase I Trial Services
  • 6.2.2. Phase II Trial Services
  • 6.2.3. Phase III Trial Services
  • 6.2.4. Phase IV Trial Services
• 6.3. Drug Discovery
  • 6.3.1. Lead Identification
  • 6.3.2. Lead Optimization
  • 6.3.3. Target Validation
• 6.4. Pre-Clinical

7. Healthcare Contract Research Organization Market, by Service

• 7.1. Introduction
• 7.2. Bio-Statistics
• 7.3. Clinical Monitoring
• 7.4. Data Management
• 7.5. Investigator Payments
• 7.6. Laboratory
• 7.7. Medical Writing
• 7.8. Patient & Site Recruitment
• 7.9. Project Management/Clinical Supply Management
• 7.10. Quality Management/ Assurance
• 7.11. Regulatory/Medical Affairs
• 7.12. Technology

8. Americas Healthcare Contract Research Organization Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Healthcare Contract Research Organization Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Research Organization Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Clinical
• 2. Charles River Laboratories, Inc.
• 3. Eurofins Scientific SE
• 4. ICON plc
• 5. IQVIA Inc.
• 6. KCR S.A.
• 7. Labcorp Drug Development
• 8. Medpace, Inc.
• 9. Parexel International Corporation
• 10. Pharmaron
• 11. PPD LLC by Thermo Fisher Scientific Inc.
• 12. SGS Societe Generale de Surveillance SA
• 13. Syneos Health
• 14. Syngene International Limited
• 15. WuXi AppTec